Dr Finkel commenced as Australia’s Chief Scientist on 25 January 2016. He is Australia’s eighth Chief Scientist.
Dr Finkel has an extensive science background as an entrepreneur, engineer, neuroscientist and educator.
Prior to becoming Chief Scientist, he was the Chancellor of Monash University and President of the Australian Academy of Technology and Engineering (ATSE).
Dr Finkel was awarded his PhD in electrical engineering from Monash University and worked as a postdoctoral research fellow in neuroscience at the Australian National University.
In 1983 he founded Axon Instruments, a California-based, ASX-listed company that made precision scientific instruments used at pharmaceutical companies and universities for the discovery of new medicines. After Axon was sold in 2004, Dr Finkel became a director of the acquiring company, NASDAQ-listed Molecular Devices.
In 2006, he returned to Australia and undertook a wide range of activities. He led the amalgamation that formed the Florey Neuroscience Institutes; he became Chair of the Australian Centre of Excellence for All-Sky Astrophysics (CAASTRO) and was a director of the ASX-listed diagnostics company Cogstate Limited. He was Executive Chair of the educational software company Stile Education, Chair of Manhattan Investment Group, Chief Technology Officer of Better Place Australia and Chair of Speedpanel Australia.
Committed to science education, Dr Finkel co-founded Cosmos Magazine, which in addition to magazine publishing operates a secondary schools science education program. At ATSE, he led the development and implementation of the STELR program for secondary school science, which has been adopted in nearly 500 Australian schools. Dr Finkel also established the Australian Course in Advanced Neuroscience to train early career neuroscientists.